Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncolytic virus therapy--foreword.

H Kasuya1, S Takeda, S Shimoyama

  • 1Department of Surgery II, Nagoya University School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan. hidekikasuya@aol.com

Current Cancer Drug Targets
|March 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression.

ESMO real world data and digital oncology·2026
Same author

Predictive capability of material screening by fast neutron activation analysis using laser-driven neutron sources.

The Review of scientific instruments·2022
Same author

Association of symptomatic gallstones and primary hyperparathyroidism: a propensity score-matched analysis.

The British journal of surgery·2021
Same author

Graft-infiltrating host dendritic cells play a key role in organ transplant rejection.

Nature communications·2016
Same author

Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis.

Clinical and experimental immunology·2015
Same author

The circadian clock functions as a potent regulator of allergic reaction.

Allergy·2015
Same journal

Targeted Chemotherapy of Human Breast Cancer Cells Using Docetaxel-Loaded Nanodroplets Coated with Bovine Serum Albumin and Functionalized with Trastuzumab.

Current cancer drug targets·2026
Same journal

Coordinated Roles of T Cells and Natural Killer Cells in Tumor Immunity.

Current cancer drug targets·2026
Same journal

Multi-omics Signature Predicts Anti-EGFR Therapy Benefit in Colorectal Cancer Liver Metastases: A Multi-center Cohort Study.

Current cancer drug targets·2026
Same journal

Anticancer Effect and Mechanism of Novel c-Myc Inhibitor BP1 on Hepatocellular Carcinoma.

Current cancer drug targets·2026
Same journal

Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic Abilities of Erlotinib in Pancreatic Cancer.

Current cancer drug targets·2026
Same journal

Corrigendum to: Migrasomes: A Novel Target for Cancer Treatment.

Current cancer drug targets·2026
See all related articles

This special issue highlights advances in oncolytic virus therapy, showcasing research on adenoviruses, vaccinia viruses, herpes viruses, and Newcastle disease viruses. It includes clinical trial results and expert opinions on cutting-edge cancer treatments.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Oncolytic virus therapy represents a promising frontier in cancer treatment.
  • This special issue consolidates current knowledge and expert reviews in the field.

Observation:

  • The issue covers diverse oncolytic viruses including adenovirus, vaccinia virus, herpes virus, and Newcastle disease virus.
  • It features contributions from leading global authorities in oncolytic virotherapy.
  • Government drug organization perspectives are also included.

Findings:

  • Recent clinical trials demonstrate encouraging results for oncolytic virus treatments.
  • H101 has been approved by the Chinese FDA after extensive patient trials.
  • PV701 has undergone trials in over 110 patients.

Related Experiment Videos

Implications:

  • This compilation offers the latest insights for researchers and clinicians in cancer therapy.
  • It underscores the growing potential and clinical validation of oncolytic viruses.
  • The findings pave the way for future advancements in viral oncology treatments.